KRAS and ovarian neoplasm: Using a Kras, Myc, FAK (KMF) syngeneic ovarian tumor mouse model, decreased tumor burden, suppressed ascites KMF-associated CD155/Polio Virus Receptor (PVR) levels, and increased peritoneal TILs were observed with blocked FAK activity.